Clean O3, LLC — Department of Defense SBIR Phase II: AF221-DCSO1
Clean O3, LLC — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,072,407 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Topic code AF221-DCSO1 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $1,072,407
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase II
- Topic
- AF221-DCSO1
- Solicitation
- X22.1
- NAICS
- —
- Place of performance
- KS
- Period
- 2022-05-06 → 2024-02-05
Description
As the landscape of warfighting changes and units are forced to hold casualties at earlier roles of care for longer periods of time, a new type of ruggedized and field deployable surgical equipment sterilization system is required. Clean O3 will leverage design and technology from their existing healthcare and ruggedized consumer products to develop a new design specific for military field hospital deployability. The Clean O3 sterilization system uses electrically generated atomized tri-molecular oxygen (ozone) to thoroughly and reliably disinfect any surface, crack or crevice without harming sensitive equipment. During third-party lab-tests, Clean O3’s system was up to 99.9% effective at killing Influenza , MRSA, Staphylococcus, SARS-CoV-2 and many other harmful bacteria and viruses. Clean O3’s team of engineers, scientists, manufacturing specialists, and network of strategic partnerships have a proven track record of delivering innovative sterilization systems for a wide range of use cases that include: medical, schools, homes, police and fire, hunters, and a whole-aircraft sterilization system currently in development.